Recommended Pages at contractservices.pharmaceutical-business-review.com
Intellipharmaceutics, Par Pharmaceutical expand ADHD drug deal - Pharmaceutical Business Review
contractservices.pharmaceutical-business-review.com — “Intellipharmaceutics International and Par Pharmaceutical have added the development and commercialization of additional strengths of generic Focalin” View full resource at contractservices.pharmaceutical-business-review.com
Most Recently Shared on August 19, 2011 at 8:38 am By:
Intellipharmaceutics, Par Pharmaceutical expand ADHD drug deal http://t.co/RcYAZKl
Sanofi-aventis, Sunnybrook to jointly develop diabetic foot ulcer treatment - Pharmaceutical Business Review
contractservices.pharmaceutical-business-review.com — “Sanofi-aventis and Toronto-based Sunnybrook Health Sciences Centre have entered into a research agreement and licensing option for vasculotide, an inv” View full resource at contractservices.pharmaceutical-business-review.com
Most Recently Shared on February 23, 2011 at 6:05 pm By:
Hai-En Peng, DPM Podiatrist and Doctor
2 companies join forces to develop a new DFU product called vasculotide... http://fb.me/G4X9DdpH
UCB forges license agreement with Synosia for neurology compounds - Pharmaceutical Business Review
contractservices.pharmaceutical-business-review.com — “UCB and Synosia have entered into a license agreement, under which UCB has received license for exclusive, worldwide rights to develop compound SYN-11” View full resource at contractservices.pharmaceutical-business-review.com
Most Recently Shared on October 14, 2010 at 4:58 am By:
UCB forges license agreement with Synosia for neurology compounds http://goo.gl/a0WC #pharmaceutical
